Physician profile
Michael J Will
NPI 1720046493
$16,375.83
in general payments reported to CMS, 2019-2025
15 companies · $4,126 in 2025
The $4,126 reported for 2025 was more than what 97% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,009 · 2020: $1,037 · 2021: $3,743 · 2022: $569 · 2023: $584 · 2024: $307 · 2025: $4,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,000 · Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,000.00 |
| Food and Beverage | $1,016.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $9,305.88 | 2019-2022 | |
| Southern Implants North America INC | $5,631.92 | 2019-2025 | Inverta |
| Nobel Biocare USA | $693.29 | 2019-2023 | Nobelactive |
| Allergan, INC. | $193.30 | 2019-2021 | |
| Stryker Corporation | $118.26 | 2022 | |
| Zimmer Biomet Holdings, INC. | $68.19 | 2019 | |
| Mentor Worldwide LLC | $66.96 | 2020-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Geistlich Pharma, North America, INC. | $57.93 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $52.82 | 2021 | |
| Straumann USA LLC | $47.66 | 2022-2025 | |
| Zimvie INC. | $42.11 | 2025 | |
| Kls-Martin L.P. | $27.59 | 2019 | |
| Biohorizons Implant Systems INC. | $27.00 | 2025 | Biohorizons Dental Implants |
| Abbott Laboratories | $21.81 | 2025 | Octrode |
| Zest Holdings, LLC | $21.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Will listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.